TALPHERA, INC. — Director's Dealing 2018

Jun 14, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACELRX PHARMACEUTICALS INC (ACRX)
CIK: 0001427925
Period of Report: 2018-06-14

Reporting Person: EDWARDS MARK G (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-14	Stock Options (Right to Buy)	$4.125	A	15000	Acquired	2028-06-14	Common Stock (15000)	Direct

Footnotes

F1: The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service to the Company.

F2: 100% Acceleration upon Change of Control.